AbCellera Biologics Inc. (ABCL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AbCellera Biologics Inc.

    NASDAQ: ABCL · Real-Time Price · USD
    4.74
    0.09 (1.94%)
    At close: Sep 26, 2025, 3:59 PM
    4.75
    0.21%
    After-hours: Sep 26, 2025, 07:57 PM EDT

    AbCellera Biologics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 28.83M 38.02M 485.42M 375.2M
    Cost of Revenue
    		 97M 30.89M 66.44M 45.52M
    Gross Profit
    		 -68.17M 7.13M 418.99M 329.69M
    Operating Income
    		 -314.77M -237.21M 216.51M 204.41M
    Interest Income
    		 38.47M 42.25M 16.08M 3.33M
    Pretax Income
    		 -200.4M -174.03M 239.1M 219.15M
    Net Income
    		 -162.86M -146.4M 158.52M 153.46M
    Selling & General & Admin
    		 85.49M 75.18M 66.75M 48.76M
    Research & Development
    		 167.26M 175.66M 107.88M 62.06M
    Other Expenses
    		 -6.15M 24.39M 17.29M -3.04M
    Operating Expenses
    		 246.6M 275.23M 191.92M 107.79M
    Interest Expense
    		 n/a n/a 4.04M 5.22M
    Selling & Marketing Expenses
    		 12.78M 14.18M 11.27M 6.91M
    Cost & Expenses
    		 343.6M 275.23M 258.36M 153.3M
    Income Tax Expense
    		 -37.54M -27.63M 80.58M 65.69M
    Shares Outstanding (Basic)
    		 294.33M 289.17M 285.06M 275.76M
    Shares Outstanding (Diluted)
    		 294.33M 289.17M 314.83M 318.29M
    EPS (Basic)
    		 -0.55 -0.51 0.56 0.56
    EPS (Diluted)
    		 -0.55 -0.51 0.50 0.48
    EBITDA
    		 -204.15M -192.16M 272.2M 241.62M
    EBIT
    		 -301.15M -223.05M 227.06M 204.41M
    Depreciation & Amortization
    		 97M 30.89M 33.1M 17.25M

    Add to Watchlist